Given that pioglitazone was a drug used in the management of type 2 diabetes mellitus, which was also identified an interaction between pioglitazone and CISD1 in this study, we speculated that CISD1, a key role in ferroptosis, might be a significant target for treating BRCA with diabetes mellitus. Here, CISD1 is linked to diabetes mellitus.